- Home
- FVRR vs IFRX Comparison
FVRR vs IFRX Comparison
Compare FVRR & IFRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | FVRR | IFRX |
|---|---|---|
| Founded | 2010 | 2007 |
| Country | Israel | Germany |
| Employees | 528 | N/A |
| Industry | Business Services | Biotechnology: Pharmaceutical Preparations |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 310.6M | 303.4M |
| IPO Year | 2019 | 2017 |
Fundamental Metrics
Financial Performance| Metric | FVRR | IFRX |
|---|---|---|
| Price | $8.71 | $1.61 |
| Analyst Decision | Hold | Strong Buy |
| Analyst Count | 10 | 9 |
| Target Price | ★ $10.75 | $7.68 |
| AVG Volume (30 Days) | ★ 528.1K | 517.1K |
| Earning Date | 11-04-2026 | 11-09-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | $22.05 | ★ N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $8.31 | $0.80 |
| 52 Week High | $23.85 | $2.95 |
Technical Indicators
Market Signals| Indicator | FVRR | IFRX |
|---|---|---|
| Relative Strength Index (RSI) | 47.50 | 32.50 |
| Support Level | $8.31 | $1.58 |
| Resistance Level | $11.43 | $2.44 |
| Average True Range (ATR) | 0.22 | 0.12 |
| MACD | 0.04 | -0.04 |
| Stochastic Oscillator | 72.32 | 19.44 |
Price Performance
Historical ComparisonAbout FVRR Fiverr International Ltd. no par value
Fiverr International Ltd operates a online marketplace that enables sellers to offer digital services and buyers to purchase them The Company's platform features an extensive catalog of digital services that spans over hundreds of categories. Buyers can purchase digital services ranging from simple services such as logo design and blog post writing, to complex services such as video creation, website development and social media marketing. Also, the Company offers value-added services including subscription products, advertising solutions and financial tools designed to support marketplace users and enhance their business activities. The company generates maximum of its revenue from USA.
About IFRX InflaRx N.V.
InflaRx NV is a biopharmaceutical company applying proprietary technologies to discover, develop and commercialize potent and specific inhibitors of the complement activation factor known as C5a and its receptor C5aR. With its therapeutic product candidates, vilobelimab and izicopan, the company targets C5a and its receptor C5aR to selectively inhibit the powerful inflammatory response observed in a wide variety of autoimmune and other inflammatory diseases elicited through C5a/C5aR activation. Its product candidate, GOHIBIC (vilobelimab), is a novel intravenously delivered anti-C5a monoclonal antibody that selectively binds to free C5a and has demonstrated disease-modifying clinical activity and tolerability in multiple clinical settings.